Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-... by Li Xinqun, Liang Ke, Lu Yang, Fan Zhen

Get full text